We have located links that may give you full text access.
JOURNAL ARTICLE
RESEARCH SUPPORT, NON-U.S. GOV'T
Leukoplakia, lichen planus, and other oral keratoses in 23,616 white Americans over the age of 35 years.
This investigation provides the first detailed population-based reporting of white keratotic lesions of the oral mucosa in a United States population. More than 21% of 3,783 oral mucosal and connective tissue lesions reported from 23,616 white Americans, usually over 35 years of age, were keratotic lesions, representing 3.4% of the entire group of examinees. Leukoplakia was the most common of all lesions diagnosed and was the most common of the keratotic lesions (85.5% of the latter). The prevalence rate for leukoplakia was 28.9/1,000 white Americans over 35 years of age and was twice as high for males as for females (43.2/1,000 males versus 20.9/1,000 females). Age-specific leukoplakia prevalence rates demonstrated a tenfold increase for males from the third to the eighth decade of life, and twofold increase for females from the fourth to the seventh decade. Sites of leukoplakia involvement, in decreasing order of frequency, were lip vermillion, buccal mucosa, mandibular gingiva, tongue, oral floor, hard palate, maxillary gingiva, lip mucosa, and soft palate. Almost 7% of leukoplakias demonstrated carcinoma or severe dysplasia microscopically. Prevalence rates for other white oral mucosal lesions were tobacco/snuff pouch keratosis, 1.6/1,000; chronic cheek bite, 1.2/1,000; lichen planus, 1.1/1,000; palatitis nicotina, 0.7/1,000; and leukoedema, 0.3/1,000.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app